Re: Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction Bacillus Calmette-Guerin therapy

被引：1
|
作者：
Krajewski, Wojciech [1 ]
Zdrojowy, Romuald [1 ]
Kolodziej, Anna [1 ]
机构：
[1] Wroclaw Med Univ, Dept Urol & Oncol Urol, Wroclaw, Poland
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2019年 / 37卷 / 06期
关键词：
Nonmuscle-invasive bladder cancer; Bacillus Calmette-Guerin; Recurrence; Progression; Purified protein derivative skin test;
D O I：
10.1016/j.urolonc.2019.01.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [1] Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Guerin therapy
    Niwa, Naoya
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Kosaka, Takeo
    Mizuno, Ryuichi
    Oya, Mototsugu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (02) : 77.e15 - 77.e21
  • [2] Purified Protein Derivative Skin test prior to bacillus Calmette-Guerin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer
    Niwa, Naoya
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Kosaka, Takeo
    Mizuno, Ryuichi
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2018, 199 (06): : 1447 - 1451
  • [3] Purified Protein Derivative Skin test prior to bacillus Calmette-Guerin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer EDITORIAL COMMENT
    Svatek, Robert S.
    JOURNAL OF UROLOGY, 2018, 199 (06): : 1452 - 1452
  • [4] PURIFIED PROTEIN DERIVATIVE SKIN TEST PRIOR TO BACILLUS CALMETTE-GUERIN THERAPY ENHANCES THE CLINICAL EFFICACY OF BCG THERAPY IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
    Niwa, Naoya
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Kosaka, Takeo
    Mizuno, Ryuichi
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2018, 199 (04): : E97 - E97
  • [5] Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: Implications for Clinical Trial Design
    Montorsi, Francesco
    Moschini, Marco
    Necchi, Andrea
    Deho, Federico
    Gandaglia, Giorgio
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2021, 206 (06): : 1528 - 1528
  • [6] Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
    Khanna, Abhinav
    Yerram, Nitin
    Zhu, Hui
    Kim, Simon
    Abouassaly, Robert
    UROLOGY, 2019, 124 : 120 - 125
  • [7] Outcomes of Intravesical bacillus Calmette-Guerin in a Multiracial Cohort with Nonmuscle Invasive Bladder Cancer
    Barry, Emily
    Agalliu, Ilir
    Maiman, Richard
    Shreck, Evan
    Kovac, Evan
    Aboumohamed, Ahmed
    Sankin, Alexander
    UROLOGY PRACTICE, 2021, 8 (01) : 100 - 105
  • [8] Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guerin: Implications for Clinical Trial Design REPLY
    不详
    JOURNAL OF UROLOGY, 2021, 205 (06): : 1620 - 1621
  • [9] The impact on survival outcomes of different Bacillus Calmette-Guerin strains of nonmuscle invasive bladder cancer patients
    Liu, K.
    Zhao, H.
    Chen, X.
    Chiu, P. K.
    Ng, C.
    Teoh, J. Y.
    EUROPEAN UROLOGY, 2023, 83 : S396 - S396
  • [10] The clinical role of purified protein derivative skin test reaction in patients with non-muscle invasive bladder cancer treated with bacillus-Calmette Guerin.
    Kikuchi, Eiji
    Niwa, Naoya
    Hayakawa, Nozomi
    Mizuno, Ryuichi
    Oya, Mototsugu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345